Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171819
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLozano-Madrid, María-
dc.contributor.authorBryan, Danielle Clark-
dc.contributor.authorGranero, Roser-
dc.contributor.authorSánchez Zaplana, Isabel-
dc.contributor.authorRiesco, Nadine-
dc.contributor.authorMallorquí-Bagué, Núria-
dc.contributor.authorJiménez-Murcia, Susana-
dc.contributor.authorTreasure, Janet-
dc.contributor.authorFernández Aranda, Fernando-
dc.date.accessioned2020-11-09T10:10:04Z-
dc.date.available2020-11-09T10:10:04Z-
dc.date.issued2020-06-01-
dc.identifier.urihttp://hdl.handle.net/2445/171819-
dc.description.abstractBackground: Empirical data suggests a high comorbid occurrence of eating disorders (EDs) and substance use disorders (SUDs), as well as neurological and psychological shared characteristics. However, no prior study has identified the neuropsychological features of this subgroup. This study examines the prevalence of alcohol and/or drug abuse (A/DA) symptoms in ED patients. It also compares the clinical features and neuropsychological performance of ED patients with and without A/DA symptoms. Methods: 145 participants (74.5% females) with various forms of diagnosed EDs underwent a comprehensive clinical (TCI-R, SCL-90-R and EDI-2) and neuropsychological assessment (Stroop, WCST and IGT). Results: Approximately 19% of ED patients (across ED subtypes) had A/DA symptoms. Those with A/DA symptoms showed more impulsive behaviours and higher levels of interoceptive awareness (EDI-2), somatisation (SCL-90-R) and novelty seeking (TCI-R). This group also had a lower score in the Stroop-words measure, made more perseverative errors in the WCST and showed a weaker learning trajectory in the IGT. Conclusions: ED patients with A/DA symptoms display a specific phenotype characterised by greater impulsive personality, emotional dysregulation and problems with executive control. Patients with these temperamental traits may be at high risk of developing a SUD.-
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/jcm9061936-
dc.relation.ispartofJournal Oo Clinical Medicine, 2020, vol. 9, num. 6-
dc.relation.urihttps://doi.org/10.3390/jcm9061936-
dc.rightscc by (c) Lozano-Madrid et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationTrastorns de la gana-
dc.subject.classificationAlcoholisme-
dc.subject.classificationDrogoaddicció-
dc.subject.classificationConducta compulsiva-
dc.subject.otherAppetite disorders-
dc.subject.otherAlcoholism-
dc.subject.otherDrug addiction-
dc.subject.otherCompulsive behavior-
dc.titleImpulsivity, emotional dysregulation and executive function deficits could be associated with alcohol and drug abuse in eating disorders-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec704659-
dc.date.updated2020-11-03T17:11:45Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid32575816-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Lozano-MadridM.pdf467.59 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons